Curing Hard-to-Treat Hepatitis C

Content From: National Institute of Allergy and Infectious DiseasesPublished: June 12, 20151 min read


In a new video, NIH researchers and their colleagues from health centers in the District of Columbia discuss efforts to improve treatments for hepatitis C, a potentially life-threatening viral disease that slowly damages the liver. NIH-sponsored clinical studies in the nation’s capital focus on identifying effective, safe, and convenient therapies for hard-to-treat hepatitis C patients, such as those who also have HIV.